Initiation of metformin in MELAS patient–a dangerous combination

Joshua Trebacha Ronald O. Perelman Department of Emergency Medicine, Division of Medical Toxicology, NYU Grossman School of Medicine, New York, NY, USA;b Department of Health and Mental Hygiene, New York City Poison Control Center, New York, NY, USACorrespondence[email protected]

Danish Ghazalic Department of Neurology, Columbia University Medical Center, New York, NY, USA

Devin J. Burkec Department of Neurology, Columbia University Medical Center, New York, NY, USA

Sarah G. Mahonskia Ronald O. Perelman Department of Emergency Medicine, Division of Medical Toxicology, NYU Grossman School of Medicine, New York, NY, USA;b Department of Health and Mental Hygiene, New York City Poison Control Center, New York, NY, USA

Robert S. Hoffmana Ronald O. Perelman Department of Emergency Medicine, Division of Medical Toxicology, NYU Grossman School of Medicine, New York, NY, USA;b Department of Health and Mental Hygiene, New York City Poison Control Center, New York, NY, USA

References

Pia S, Lui F. Melas syndrome. [updated 2021 mar 24]. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532959/
Google Scholar
Horváth R, Reilmann R, Holinski-Feder E, et al. The role of complex I genes in MELAS: a novel heteroplasmic mutation 3380G>a in ND1 of mtDNA. Neuromuscul Disord. 2008;18(7):553–556.
PubMed Web of Science ®Google Scholar
El-Hattab AW, Almannai M, Scaglia F, et al. MELAS [updated 2018 Nov 29]. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews® [internet]. Seattle (WA): University of Washington, Seattle; 2001. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1233/
Google Scholar
Kim NH, Siddiqui M, Vogel J. MELAS syndrome and MIDD unmasked by metformin use: a case report. Ann Intern Med. 2021;174(1):124–125.
PubMed Web of Science ®Google Scholar
Yee ML, Wong R, Datta M, et al. Mitochondrial disease: an uncommon but important cause of diabetes mellitus. Endocrinol Diabetes Metab Case Rep. 2019;2018:18–0091.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Initiation of metformin in MELAS patient–a dangerous combination

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Initiation of metformin in MELAS patient–a dangerous combination

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date